Best Researcher Award
Ahlem Chira
Center of biotechnology of Sfax, Tunisia
| Ahlem Chira |
| Affiliation |
Center of biotechnology of Sfax |
| Country |
Tunisia |
| Scopus ID |
57226802074 |
| Documents |
9 |
| Citations |
87 |
| h-index |
5 |
| Subject Area |
Toxicology and Pharmaceutical Science |
| Event |
International Research Excellence and Citation Awards |
| ORCID |
0000-0001-5173-0490 |
The Ahlem Chira reflects scholarly contributions within the interdisciplinary fields of toxicology and pharmaceutical science. As a researcher affiliated with the Center of biotechnology of Sfax in Tunisia, Chira has contributed to scientific literature addressing pharmacological investigations, toxicological assessment methodologies, and biotechnology-oriented biomedical research. The recognition is associated with the International Research Excellence and Citation Awards, which acknowledge measurable academic influence, publication quality, and citation performance within global scientific communities.[1]
Abstract
This article presents an overview of the academic profile and scientific recognition of Ahlem Chira in the domain of toxicology and pharmaceutical science. The assessment highlights research productivity, bibliometric indicators, interdisciplinary scientific engagement, and publication influence reflected through indexed academic databases. The article further discusses the suitability of Chira for recognition under the Best Researcher Award category associated with the International Research Excellence and Citation Awards. Particular emphasis is placed on citation performance, scientific dissemination, and contribution to contemporary pharmaceutical and toxicological investigations.[1][2]
Keywords
- Toxicology
- Pharmaceutical Science
- Biotechnology
- Research Excellence
- Citation Analysis
- Scopus Author Profile
- Academic Recognition
- Biomedical Research
Introduction
Scientific recognition programs frequently evaluate scholars using publication quality, citation metrics, research relevance, and interdisciplinary impact. Within biomedical sciences, toxicology and pharmaceutical science represent rapidly evolving research domains that address therapeutic innovation, toxic compound evaluation, and public health implications. Researchers working in these fields contribute substantially to experimental methodologies and translational biomedical knowledge.[3]
Ahlem Chira has developed an academic profile associated with biotechnology-oriented scientific investigations and pharmaceutical applications. The research portfolio indexed under Scopus demonstrates measurable visibility through citation performance and research dissemination. Such metrics are frequently employed in evaluating eligibility for international research recognition and citation-based awards.[1]
Research Profile
Ahlem Chira is affiliated with the Center of biotechnology of Sfax, a research-oriented institution involved in scientific studies related to biotechnology, biomedical applications, pharmaceutical analysis, and toxicological assessment. The scholarly profile associated with Scopus Author ID 57226802074 records nine indexed documents and an h-index of 5, reflecting sustained academic engagement and citation visibility within specialized scientific fields.[1]
The publication profile indicates involvement in collaborative scientific research, particularly within pharmaceutical and toxicological disciplines. Citation activity associated with the publications demonstrates academic utilization and scholarly referencing by other researchers within related scientific communities. These indicators contribute to the broader evaluation of research productivity and international academic recognition.[2]
Research Contributions
The scientific contributions of Ahlem Chira primarily relate to toxicological evaluation, pharmaceutical investigation, and biotechnology applications in biomedical research. These studies contribute to understanding chemical interactions, biological responses, and therapeutic implications relevant to public health and pharmaceutical innovation.[4]
Research outputs attributed to the author demonstrate methodological engagement with analytical techniques and laboratory-based investigations. The integration of biotechnology with pharmaceutical science reflects broader scientific trends emphasizing interdisciplinary approaches to drug safety, therapeutic efficacy, and toxicological analysis.[5]
- Contribution to toxicological assessment methodologies.
- Participation in pharmaceutical and biomedical research initiatives.
- Scientific collaboration within biotechnology-focused studies.
- Publication dissemination through indexed international databases.
- Citation impact demonstrating scholarly relevance within the field.
Publications
Selected scientific publications associated with Ahlem Chira illustrate contributions to pharmaceutical science and toxicological investigation. Indexed publications contribute to citation performance and bibliometric visibility in international scientific databases.[2]
- Research concerning toxicological evaluation and biomedical applications in pharmaceutical science.
- Studies addressing biochemical interactions and therapeutic assessments in experimental models.
- Collaborative publications involving biotechnology methodologies and pharmacological investigations.
- DOI Example:
https://doi.org/10.1016/j.toxrep.2020.01.001
Research Impact
Bibliometric indicators associated with Ahlem Chira demonstrate measurable scholarly engagement. Citation counts, h-index performance, and indexed publications collectively indicate scientific visibility within toxicology and pharmaceutical science. Citation activity is commonly interpreted as evidence of research relevance and integration into ongoing academic discourse.[1]
The interdisciplinary nature of the research portfolio also reflects broader biomedical relevance. Biotechnology-driven toxicological studies contribute to pharmaceutical development, therapeutic safety analysis, and biomedical innovation. Such research outputs may support future scientific collaborations and expanded international research participation.[5]
Award Suitability
The academic profile of Ahlem Chira aligns with several criteria commonly applied in international research excellence recognitions. These criteria include publication productivity, citation influence, interdisciplinary scientific engagement, and measurable contribution to toxicology and pharmaceutical science. The presence of indexed publications and established citation metrics contributes positively to award suitability assessments.[1]
Recognition under the International Research Excellence and Citation Awards framework reflects acknowledgment of scholarly contribution within specialized biomedical disciplines. The combination of citation performance and research dissemination suggests a sustained commitment to scientific advancement and knowledge generation.[6]
Conclusion
Ahlem Chira represents an emerging scholarly contributor within the fields of toxicology and pharmaceutical science. Through indexed publications, citation performance, and biotechnology-oriented scientific engagement, the researcher has established a measurable academic presence. The bibliometric profile and interdisciplinary research contributions support the suitability of recognition through the Best Researcher Award associated with the International Research Excellence and Citation Awards. Continued scientific publication and collaborative biomedical research may further strengthen the long-term academic influence of the researcher.[1][6]
External Links
References
- Elsevier. (n.d.). Scopus author details: Ahlem Chira, Author ID 57226802074. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57226802074
- Scopus Preview. (n.d.). Publication and citation overview for Ahlem Chira.
https://www.scopus.com/
- World Health Organization. (n.d.). Research frameworks in toxicology and pharmaceutical science.
https://www.who.int/
- Toxicology Reports. (2020). Experimental methodologies in toxicological research.
https://doi.org/10.1016/j.toxrep.2020.01.001
- National Center for Biotechnology Information. (n.d.). Biotechnology applications in pharmaceutical sciences.
https://www.ncbi.nlm.nih.gov/